Bukwang Pharm (003000) — Cash Flow Quality Index
Bukwang Pharm (003000) has a Cash Flow Quality Index of -4.08x as of September 2025. Operating cash flow of ₩-6.24 Billion is below net income of ₩1.53 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore 003000 long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Bukwang Pharm Cash Flow Quality Index (2007–2018)
Historical Cash Flow Quality Index for Bukwang Pharm across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 003000 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Bukwang Pharm (2007–2018)
Year-by-year earnings quality comparison for Bukwang Pharm. For live market cap and the full company financial profile, see Bukwang Pharm (003000) market capitalisation.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2018 | 0.05x | ₩6.82 Billion | ₩145.67 Billion | ▼ -93.9% |
| 2017 | 0.77x | ₩8.56 Billion | ₩11.09 Billion | ▲ +257.2% |
| 2016 | -0.49x | ₩-7.76 Billion | ₩15.81 Billion | ▼ -219.9% |
| 2015 | 0.41x | ₩10.30 Billion | ₩25.14 Billion | ▼ -65.3% |
| 2014 | 1.18x | ₩27.86 Billion | ₩23.62 Billion | ▼ -36.9% |
| 2013 | 1.87x | ₩36.52 Billion | ₩19.53 Billion | ▲ +120.1% |
| 2007 | 0.85x | ₩27.87 Billion | ₩32.82 Billion | — |